LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) --  MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Elsevier, a global leader in scientific information and data analytics, has been selected as winner of the “AI Innovation Award” in the 8th annual MedTech Breakthrough Awards program, recognizing the breakthrough innovation of Elsevier’s ClinicalKey AI.

2024年5月9日，洛杉矶（环球通讯社）--MedTech Breakthrough是一家独立的市场情报组织，它认可全球数字健康和医疗技术市场上的顶尖公司、技术和产品，今天宣布，科学信息和数据分析领域的全球领军者Elsevier被选为第八届年度MedTech Breakthrough Awards计划的“AI创新奖”得主，表彰Elsevier的ClinicalKey AI的突破性创新。

Elsevier partnered with OpenEvidence to develop ClinicalKey AI, expanding ClinicalKey’s capabilities with the latest AI advancements. ClinicalKey AI combines trusted, evidence-based clinical content with conversational search powered by generative AI to support clinicians in delivering high-quality patient care.

Elsevier与OpenEvidence合作开发ClinicalKey AI，利用最新的AI进步扩展ClinicalKey的功能。ClinicalKey AI将可信的，基于证据的临床内容与由生成性AI支持的对话搜索相结合，以支持临床医生提供高质量的患者护理。

ClinicalKey AI generates responses based on information from validated sources, including Elsevier’s proprietary point of care content, medical reference texts, Elsevier and trusted third-party journal abstracts, and government publications. By evaluating these evidence-based content sources that are updated daily, ClinicalKey AI can summarize a tailored response to clinical queries.

ClinicalKey AI根据来自经过验证的来源的信息生成响应，包括Elsevier专有的即时护理内容，医学参考文本，Elsevier和可信的第三方期刊摘要以及政府出版物。通过评估这些每天更新的基于证据的内容来源，ClinicalKey AI可以总结出对临床查询的定制响应。

Responses also include references with linked citations to supporting published evidence. “As a company dedicated to empowering clinicians and improving outcomes, we are committed to ensuring clinicians have access to reliable, evidence-based medical information. ClinicalKey AI is designed for clinical practice, and enables faster and more precise answers to a wide variety of clinical questions based on the latest scientific research,” said Jan Herzhoff, President of Health Markets at Elsevier.

回复还包括引用链接引用以支持已发表的证据。“作为一家致力于赋予临床医生权力和改善结果的公司，我们致力于确保临床医生能够获得可靠的循证医学信息。ClinicalKey AI是为临床实践而设计的，能够根据最新的科学研究更快，更准确地回答各种各样的临床问题，”Elsevier健康市场总裁Jan Herzhoff说。

“This is critical given the overwhelming volume of complex cases that clinicians are.

“鉴于临床医生的复杂病例数量巨大，这一点至关重要。